WEN Insider Filing: CMO Radkoski Reports RSU Vesting and Small Share Sale
Rhea-AI Filing Summary
Lindsay J. Radkoski, CMO, U.S., of The Wendy's Company (WEN) reported insider transactions on Form 4 dated 08/15/2025. The filing shows 2,577 restricted stock units (RSUs) were treated as acquired/vested and converted to common stock at no purchase price, and 770 shares of common stock were disposed of at a price of $10.57 per share.
The RSUs were originally granted on 08/15/2024 and vest in three equal annual installments; the first installment (including 141 dividend equivalent units) vested on 08/15/2025. After these transactions Ms. Radkoski beneficially owned 35,301 shares of common stock and had 109,464 shares underlying outstanding RSUs reported as beneficially owned.
Positive
- Scheduled RSU vesting occurred: 2,577 restricted stock units vested and were converted to common stock on 08/15/2025
- Dividend equivalents included: 141 dividend equivalent units accrued and were included with the vested RSUs
- Clear disclosure of grant date, vesting schedule, and resulting beneficial ownership provides transparency
Negative
- Disposition of shares: 770 shares were sold at $10.57, reducing direct beneficial ownership to 35,301 shares
- No purpose stated for the 770-share sale in the filing, so the reason for the disposition is not disclosed
Insights
TL;DR: Routine executive equity vesting and a small sale were reported; this reflects scheduled compensation vesting rather than a corporate governance event.
The Form 4 documents a scheduled vesting of RSUs granted 08/15/2024 and a contemporaneous sale of 770 shares at $10.57. The vesting follows the stated three-year annual cliff/installment schedule, with the first installment vesting on 08/15/2025 and including 141 dividend equivalents. These are standard equity compensation disclosures that update beneficial ownership counts. There is no indication in the filing of unusual timing, related-party transactions, or amendments that would raise governance concerns.
TL;DR: The report shows normal compensation settlement (2,577 RSUs vested) and a small disposition; impacts on dilution and executive stake are limited.
The 2,577 RSUs converted to common shares at $0 per unit upon vesting, increasing immediately reportable common shares. The filing notes 109,464 shares underlying RSUs remain reported as beneficially owned overall. The 770-share disposition at $10.57 modestly reduced reported direct holdings to 35,301 shares. These movements are consistent with customary equity award vesting schedules and routine sales tied to vested awards or other needs; the filing does not disclose the purpose of the sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 2,577 | $0.00 | -- |
| Exercise | Common Stock | 2,577 | $0.00 | -- |
| Tax Withholding | Common Stock | 770 | $10.57 | $8K |
Footnotes (1)
- Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. With tandem dividend equivalent rights and tax withholding rights. Includes 141 dividend equivalent units that had accrued on the restricted stock units. The restricted stock units were granted on August 15, 2024 and vest in three equal installments on the first, second and third anniversaries of the grant date, subject to Ms. Radkoski's continued employment with the Company on the applicable vesting date. The first installment (including the related dividend equivalent units) vested on August 15, 2025.
